|[March 21, 2014]
In Response to Imminent March 31st Deadline, MMIS Launches MediSpend® Validate, the Solution to CMS Phase I Reporting for Life Science Companies
PORTSMOUTH, N.H. --(Business Wire)--
MMIS launches MediSpend®
Validate the first, free Open Payments validation and analysis tool
for life science companies in the US. MediSpend® Validate has
enhanced functionality to easily generate the CMS
Phase I report as required by CMS for submission on or before March
"This is a major accomplishment for our team and a free service for our
customers. Since the CMS announcement of the two-phased submission
approach (released February 8, 2014), our team of highly trained IT
specialists and legal experts have updated MediSpend®
Validate to include the new critical functionality needed to produce the
Phase I report. Our primary goal at MMIS is to streamline the aggregate
spend reporting process, with intuitive and comprehensive modular
solutions," said Michaeline Daboul, President & CEO.
MediSpend® Validate plays a critical role in the reporting
process. With hundreds of thousands of transactions to be reported
annually to the Federal government, the ability to perform a validation
check of the data helps to ensure data quality and compliance with the
US Open Payments requirements.
MediSpend® Validate can be paired with any aggregate
spend reporting system. In fact, as a stand-alone validation tool,
MediSpend® Validate does not require the use or purchase of
any other aggregate spend reporting system. As long as the data is
prepared for CMS submission, using the CMS templates, MediSpend® Validate
will perform hndreds of checks using validation algorithms designed by
subject matter experts and based on the CMS Federal report templates and
"We decided to build this module as part of the MediSpend® Global
Compliance platform in order to give non-MediSpend® customers
the ability to test their data prior to the required upload to CMS,"
states Daboul. "Producing a 'score card' indicating specific errors in
the data set, MediSpend® Validate empowers life science
companies to proactively check, review and analyze their data quality
prior to submission."
Current MediSpend customers already enjoy the benefits of validation,
and MMIS's assistance generating the CMS Phase 1 Report, by using
MediSpend®. "At an affordable cost, MediSpend®
Validate, is an easy-to-use service, that should be incorporated into
every company's data review and analysis process," states Daboul.
For more information on MediSpend®
Validate and how to incorporate into your aggregate spend process
please contact Colby Jacobson at +1(888) 731-7322 x 8121 or send an
email to email@example.com.
About MMIS, Inc.
is a global technology company providing compliance and business
intelligence solutions for the life science industry. The MediSpend®
Global Compliance SaaS (News - Alert) solution addresses state, federal and global
transparency laws. Developed using a proprietary rules-based system with
tremendous flexibility and speed of update, MediSpend® solves
the aggregate spend tracking and reporting problem. MediSpend® incorporates
master data management (MDM) with a workflow designed to automate data
entry from enterprise source systems and transforms data into reports
required for state, federal and global jurisdictions.
MediSpend® Data Analytics is a cloud-based software solution
that uses behavioral data analytics to help life science executives make
skilled business decisions. MediSpend® Data Analytics enables
our customers to capture rich data about their own behavior with the
healthcare community turning market and aggregate spend data into
actionable, business insights.
Our customers benefit from our proprietary data aggregation and analysis
tools: MediSpend® (aggregate spend tracking and reporting
tool), MediSpend® Notification and Dispute Resolution tool
(manage and exchange data with physicians and healthcare organizations
to resolve disputes), MediSpend® Data Analytics (Business
Intelligence tool) and the Physicians Professional Network® (PPN)
(a cloud-based platform to enable physician-to-physician and
physician-to-industry connections. The PPN allows physicians to review
and dispute--if necessary--spend data to be reported by pharmaceutical
and medical device companies and create and maintain a personal
Developed by attorneys and IT specialists with over 25 years of
experience in healthcare compliance, the MediSpend® Global
Compliance solution represents the first end-to-end compliance and data
analytics SaaS solution designed specifically to help life science
executives make better-informed business decisions while ensuring
compliance with global transparency laws.
To learn more, please visit: www.mmis-inc.com
Follow us on Twitter (News - Alert) @medispend
[ Back To TMCnet.com's Homepage ]